Regeneron: Market Overlooks A Resilient Franchise And Robust Free Cash Flow
Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...
Pollard Banknote: Repricing For A Winning Hand In 2025
Despite a weak Q4'24, Pollard Banknote's (PBL:CA) charitable gaming segment and NeoPollard JV show strong potential. See why I continue to rate the stock a buy.